Optimel secures its niche
In Part 4 of Insight's dry eye series, Melcare Biomedical CEO Anthony Moloney reveals how his company's Australian-made product has ...
In Part 4 of Insight's dry eye series, Melcare Biomedical CEO Anthony Moloney reveals how his company's Australian-made product has ...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited